Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts

医学 鉴定(生物学) 内科学 前瞻性队列研究 星团(航天器) 疾病 横断面研究 病理 生物 计算机科学 生态学 程序设计语言
作者
Yann Nguyen,Gaëtane Nocturne,Julien Henry,Wan‐Fai Ng,Rakiba Belkhir,Frédéric Desmoulins,Elisabeth Berge,Jacques Morel,Aleth Perdriger,Emmanuelle Dernis,Valérie Devauchelle‐Pensec,D. Sène,Philippe Dieudé,Marion Couderc,A.L. Fauchais,C. Larroche,Olivier Vittecoq,Carine Salliot,Eric HACHULLA,Véronique Le Guern
出处
期刊:The Lancet Rheumatology [Elsevier BV]
卷期号:6 (4): e216-e225 被引量:102
标识
DOI:10.1016/s2665-9913(23)00340-5
摘要

BACKGROUND: Sjögren's disease is a heterogenous autoimmune disease with a wide range of symptoms-including dryness, fatigue, and pain-in addition to systemic manifestations and an increased risk of lymphoma. We aimed to identify distinct subgroups of the disease, using cluster analysis based on subjective symptoms and clinical and biological manifestations, and to compare the prognoses of patients in these subgroups. METHODS: This study included patients with Sjögren's disease from two independent cohorts in France: the cross-sectional Paris-Saclay cohort and the prospective Assessment of Systemic Signs and Evolution of Sjögren's Syndrome (ASSESS) cohort. We first used an unsupervised multiple correspondence analysis to identify clusters within the Paris-Saclay cohort using 26 variables comprising patient-reported symptoms and clinical and biological manifestations. Next, we validated these clusters using patients from the ASSESS cohort. Changes in disease activity (measured by the European Alliance of Associations for Rheumatology [EULAR] Sjögren's Syndrome Disease Activity Index [ESSDAI]), patient-acceptable symptom state (measured by the EULAR Sjögren's Syndrome Patient Reported Index [ESSPRI]), and lymphoma incidence during follow-up were compared between clusters. Finally, we compared our clusters with the symptom-based subgroups previously described by Tarn and colleagues. FINDINGS: 534 patients from the Paris-Saclay cohort (502 [94%] women, 32 [6%] men, median age 54 years [IQR 43-64]), recruited between 1999 and 2022, and 395 patients from the ASSESS cohort (370 [94%] women, 25 [6%] men, median age 53 years [43-63]), recruited between 2006 and 2009, were included in this study. In both cohorts, hierarchical cluster analysis revealed three distinct subgroups of patients: those with B-cell active disease and low symptom burden (BALS), those with high systemic disease activity (HSA), and those with low systemic disease activity and high symptom burden (LSAHS). During follow-up in the ASSESS cohort, disease activity and symptom states worsened for patients in the BALS cluster (67 [36%] of 186 patients with ESSPRI score <5 at month 60 vs 92 [49%] of 186 at inclusion; p<0·0001). Lymphomas occurred in patients in the BALS cluster (five [3%] of 186 patients; diagnosed a median of 70 months [IQR 42-104] after inclusion) and the HSA cluster (six [4%] of 158 patients; diagnosed 23 months [13-83] after inclusion). All patients from the Paris-Saclay cohort with a history of lymphoma were in the BALS and HSA clusters. This unsupervised clustering classification based on symptoms and clinical and biological manifestations did not correlate with a previous classification based on symptoms only. INTERPRETATION: On the basis of symptoms and clinical and biological manifestations, we identified three distinct subgroups of patients with Sjögren's disease with different prognoses. Our results suggest that these subgroups represent different heterogeneous pathophysiological disease mechanisms, stages of disease, or both. These findings could be of interest when stratifying patients in future therapeutic trials. FUNDING: Fondation pour la Recherche Médicale, French Ministry of Health, French Society of Rheumatology, Innovative Medicines Initiative 2 Joint Undertaking, Medical Research Council UK, and Foundation for Research in Rheumatology.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
隐形曼青的应助被热心网友123采纳,获得10
刚刚
刚刚
汉堡包的应助被山水采纳,获得10
刚刚
1秒前
谢亚冰完成签到,获得积分10
1秒前
1秒前
共享精神的应助被苹果丑采纳,获得10
1秒前
呆瓜不呆的应助被杜冷丁采纳,获得10
1秒前
小余完成签到,获得积分10
1秒前
诸非完成签到 ,获得积分10
1秒前
呆瓜不呆的应助被杜冷丁采纳,获得10
1秒前
1秒前
Jasper的应助被爱听歌的悒采纳,获得10
1秒前
sqqx发布了新的文献求助10
2秒前
3秒前
3秒前
3秒前
3秒前
3秒前
小马甲的应助被话梅糖采纳,获得10
3秒前
3秒前
3秒前
4秒前
jerrychen完成签到,获得积分10
4秒前
积极努力发布了新的文献求助30
4秒前
4秒前
王大胆完成签到,获得积分10
5秒前
MIST完成签到,获得积分10
5秒前
sendou举报无聊的冬日的求助涉嫌违规
5秒前
5秒前
5秒前
星辰大海的应助被lp采纳,获得10
5秒前
zhangmingyang发布了新的文献求助10
5秒前
6秒前
烟花的应助被XJ采纳,获得10
6秒前
刘树树完成签到,获得积分10
6秒前
大个的应助被自知则知之采纳,获得10
6秒前
6秒前
鲤鱼晓瑶发布了新的文献求助10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175653
求助须知:如何正确求助?哪些是违规求助? 9567273
关于积分的说明 21791766
捐赠科研通 7770183
什么是DOI,文献DOI怎么找? 3431873
关于科研通互助平台的介绍 2556250
邀请新用户注册赠送积分活动 2477299